Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database
- PMID: 21793180
- PMCID: PMC4261144
- DOI: 10.1002/pbc.23252
Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database
Abstract
Background: Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal malignancies that occur throughout the lifespan. The impact of age on disease features and outcome is unclear.
Methods: We analyzed the clinical features and outcome of all STS cases registered between 1973 and 2006 in the SEER database.
Results: There were 48,012 cases that met the selection criteria. Individuals less than 20 years of age represented 5.6%, with rhabdomyosarcoma being the most common subtype. In adults, the most common types were Kaposi sarcoma, fibrohistiocytic tumors, and leiomyosarcoma. Rhabdomyosarcoma was the only entity with a median age <20 years. Male predominance (male/female of 1.5:1) was noticed for almost all types of STS, except for alveolar soft part sarcoma and leiomyosarcoma. Tumor stage was similar across different age groups. Younger patients (<50 years) had significantly better survival than older patients (88.8 ± 0.2% vs. 40 ± 0.3%, P < 0.001), but for most histologies the survival decline with advancing age was gradual and did not occur abruptly at the onset of adulthood. The decline in survival with advancing age was particularly significant for rhabdomyosarcoma.
Conclusion: With few exceptions, the clinical features of STS are similar in children and adults. However, individuals over 50 years of age have an inferior survival.
Copyright © 2011 Wiley-Liss, Inc.
Conflict of interest statement
The authors have no financial interest or conflict of interest to declare.
Figures
Similar articles
-
Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.J Clin Oncol. 2009 Jul 10;27(20):3391-7. doi: 10.1200/JCO.2008.19.7483. Epub 2009 Apr 27. J Clin Oncol. 2009. PMID: 19398574
-
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.Int J Cancer. 2019 Oct 15;145(8):2135-2143. doi: 10.1002/ijc.32307. Epub 2019 Apr 15. Int J Cancer. 2019. PMID: 30924137 Free PMC article.
-
Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas.Cancer Med. 2018 Dec;7(12):6030-6039. doi: 10.1002/cam4.1872. Epub 2018 Nov 19. Cancer Med. 2018. PMID: 30453392 Free PMC article.
-
Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.Cancer Invest. 2000;18(3):223-41. doi: 10.3109/07357900009031827. Cancer Invest. 2000. PMID: 10754991 Review.
-
Soft tissue sarcomas of childhood.Cancer Treat Rev. 2004 May;30(3):269-80. doi: 10.1016/j.ctrv.2003.11.001. Cancer Treat Rev. 2004. PMID: 15059650 Review. No abstract available.
Cited by
-
Scrotal Dermatofibrosarcoma Protuberans in a Patient with Schizophrenia: A Case Report and Review of the Literature.Cureus. 2024 Feb 17;16(2):e54369. doi: 10.7759/cureus.54369. eCollection 2024 Feb. Cureus. 2024. PMID: 38500933 Free PMC article.
-
The surgical management and oncologic outcomes of patients with fungating soft tissue sarcoma treated at a tertiary cancer centre and review of literature.J Orthop. 2024 Mar 1;53:94-100. doi: 10.1016/j.jor.2024.02.013. eCollection 2024 Jul. J Orthop. 2024. PMID: 38495576 Review.
-
Clinical characteristics and management of primary retroperitoneal sarcoma: A literature review.Ann Gastroenterol Surg. 2023 Nov 16;8(1):21-29. doi: 10.1002/ags3.12756. eCollection 2024 Jan. Ann Gastroenterol Surg. 2023. PMID: 38250690 Free PMC article. Review.
-
Inguinal synovial sarcoma revealed by a limb swelling: A case report.Int J Surg Case Rep. 2024 Feb;115:109252. doi: 10.1016/j.ijscr.2024.109252. Epub 2024 Jan 12. Int J Surg Case Rep. 2024. PMID: 38241792 Free PMC article.
-
Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan.Int J Clin Oncol. 2024 Mar;29(3):345-353. doi: 10.1007/s10147-023-02453-4. Epub 2023 Dec 28. Int J Clin Oncol. 2024. PMID: 38155238
References
-
- Weiss S, Goldblum J. General considerations. In: Weiss S, Goldblum J, editors. Enzinger and Weiss’s Soft Tissue Tumors. St Louis, Missouri: CV Mosby; 2001. pp. 1–19.
-
- National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–2006) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2009, based on the November 2008 submission. www.seer.cancer.gov.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2008 Sub (1973–2006) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2006 Counties. ( www.seer.cancer.gov) released April 2009, based on the November 2008 submission.
-
- Levi F, Randimbison L, Te VC, et al. Kaposi’s sarcoma in Vaud and Neuchatel, Switzerland, 1978–2002. Eur J Cancer. 2004;40(10):1630–1633. - PubMed
-
- Rouhani P, Fletcher CD, Devesa SS, et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer. 2008;113(3):616–627. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
